IOVA
Iovance Biotherapeutics, Inc. · Healthcare · Biotechnology
Données momentum (gérants comparables) :
étendue des détenteurs -12.5% ·
flux d'actions -6.2% ·
nouvelles positions nettes -14.3%
— formule
Distribution large — baisse des parts et moins de détenteurs
Toutes les données de détention : gérants 13F suivis uniquement, positions en actions ordinaires, période de référence Q3 2025
| Trimestre | Détenteurs | Δ | Actions | Valeur déclarée | Nouveau | Sorties |
|---|---|---|---|---|---|---|
| Q2 2026 | 103 | +5 | 196.52M | $817.32M | +8 | −3 |
| Q1 2026 | 101 | +2 | 181.45M | $636.15M | +8 | −6 |
| Q4 2025 | 98 | +1 | 178.19M | $486.45M | +1 | — |
| Q3 2025 | 14 | -2 | 98.05M | $212.78M | — | −2 |
| Q2 2025 | 13 | -2 | 89.90M | $154.64M | — | −2 |
| Q1 2025 | 12 | +2 | 25.73M | $85.68M | +2 | — |
| Q4 2024 | 10 | 0 | 23.63M | $174.86M | +2 | −2 |
| Q3 2024 | 9 | -1 | 11.04M | $103.72M | +1 | −2 |
| Q2 2024 | 10 | — | 13.79M | $110.63M | — | — |
| # | Gérant | Actions | Δ actions | Valeur | Leur poids | Détenu | ||
|---|---|---|---|---|---|---|---|---|
| 1 | BlackRock ✦ (passif) | 25.96M | +11.7% | $56.33M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 2 | BlackRock ✦ (passif) | 25.96M | +11.7% | $56.33M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 3 | BlackRock ✦ (passif) | 25.96M | +11.7% | $56.33M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 4 | BlackRock ✦ (passif) | 25.96M | +11.7% | $56.33M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 5 | BlackRock ✦ (passif) | 25.96M | +11.7% | $56.33M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 6 | BlackRock ✦ (passif) | 25.96M | +11.7% | $56.33M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 7 | BlackRock ✦ (passif) | 25.96M | +11.7% | $56.33M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 8 | BlackRock ✦ (passif) | 25.96M | +11.7% | $56.33M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 9 | BlackRock ✦ (passif) | 25.96M | +11.7% | $56.33M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 10 | BlackRock ✦ (passif) | 25.96M | +11.7% | $56.33M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 11 | BlackRock ✦ (passif) | 25.96M | +11.7% | $56.33M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 12 | BlackRock ✦ (passif) | 25.96M | +11.7% | $56.33M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 13 | BlackRock ✦ (passif) | 25.96M | +11.7% | $56.33M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 14 | BlackRock ✦ (passif) | 25.96M | +11.7% | $56.33M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 15 | The Vanguard Group ✦ (passif) | 24.06M | -4.1% | $52.21M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 16 | The Vanguard Group ✦ (passif) | 24.06M | -4.1% | $52.21M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 17 | The Vanguard Group ✦ (passif) | 24.06M | -4.1% | $52.21M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 18 | The Vanguard Group ✦ (passif) | 24.06M | -4.1% | $52.21M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 19 | The Vanguard Group ✦ (passif) | 24.06M | -4.1% | $52.21M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 20 | State Street Global Advisors ✦ (passif) | 13.31M | +34.6% | $28.88M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 21 | Geode Capital Management ✦ (passif) | 6.87M | +11.0% | $14.91M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 22 | Geode Capital Management ✦ (passif) | 6.87M | +11.0% | $14.91M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 23 | Goldman Sachs Group ✦ | 6.58M | — | $14.27M | 0.0% | n/c | 1 | SEC ↗ |
| 24 | Goldman Sachs Group ✦ | 6.58M | — | $14.27M | 0.0% | n/c | 1 | SEC ↗ |
| 25 | Goldman Sachs Group ✦ | 6.58M | — | $14.27M | 0.0% | n/c | 1 | SEC ↗ |
| 26 | Morgan Stanley ✦ | 5.58M | — | $12.11M | 0.0% | n/c | 1 | SEC ↗ |
| 27 | Morgan Stanley ✦ | 5.58M | — | $12.11M | 0.0% | n/c | 1 | SEC ↗ |
| 28 | Morgan Stanley ✦ | 5.58M | — | $12.11M | 0.0% | n/c | 1 | SEC ↗ |
| 29 | Morgan Stanley ✦ | 5.58M | — | $12.11M | 0.0% | n/c | 1 | SEC ↗ |
| 30 | Morgan Stanley ✦ | 5.58M | — | $12.11M | 0.0% | n/c | 1 | SEC ↗ |
| 31 | Morgan Stanley ✦ | 5.58M | — | $12.11M | 0.0% | n/c | 1 | SEC ↗ |
| 32 | Morgan Stanley ✦ | 5.58M | — | $12.11M | 0.0% | n/c | 1 | SEC ↗ |
| 33 | Millennium Management ✦ | 4.41M | -52.7% | $9.58M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 34 | Citadel Advisors ✦ | 3.82M | -7.1% | $8.29M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 35 | Citadel Advisors ✦ | 3.82M | -7.1% | $8.29M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 36 | Two Sigma Investments ✦ | 2.74M | -40.9% | $5.95M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 37 | JPMorgan Chase ✦ | 2.45M | — | $5.31M | 0.0% | n/c | 1 | SEC ↗ |
| 38 | JPMorgan Chase ✦ | 2.45M | — | $5.31M | 0.0% | n/c | 1 | SEC ↗ |
| 39 | JPMorgan Chase ✦ | 2.45M | — | $5.31M | 0.0% | n/c | 1 | SEC ↗ |
| 40 | JPMorgan Chase ✦ | 2.45M | — | $5.31M | 0.0% | n/c | 1 | SEC ↗ |
| 41 | JPMorgan Chase ✦ | 2.45M | — | $5.31M | 0.0% | n/c | 1 | SEC ↗ |
| 42 | JPMorgan Chase ✦ | 2.45M | — | $5.31M | 0.0% | n/c | 1 | SEC ↗ |
| 43 | JPMorgan Chase ✦ | 2.45M | — | $5.31M | 0.0% | n/c | 1 | SEC ↗ |
| 44 | JPMorgan Chase ✦ | 2.45M | — | $5.31M | 0.0% | n/c | 1 | SEC ↗ |
| 45 | JPMorgan Chase ✦ | 2.45M | — | $5.31M | 0.0% | n/c | 1 | SEC ↗ |
| 46 | JPMorgan Chase ✦ | 2.45M | — | $5.31M | 0.0% | n/c | 1 | SEC ↗ |
| 47 | T. Rowe Price ✦ | 2.06M | -2.7% | $4.47M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 48 | T. Rowe Price ✦ | 2.06M | -2.7% | $4.47M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 49 | AQR Capital Management ✦ | 101.40K | -56.2% | $220,034 | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 50 | AQR Capital Management ✦ | 101.40K | -56.2% | $220,034 | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 51 | AQR Capital Management ✦ | 101.40K | -56.2% | $220,034 | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 52 | AQR Capital Management ✦ | 101.40K | -56.2% | $220,034 | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 53 | AQR Capital Management ✦ | 101.40K | -56.2% | $220,034 | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 54 | D. E. Shaw & Co. ✦ | 76.21K | +37.4% | $165,374 | 0.0% | ▲ Add | 6 | SEC ↗ |
| 55 | Fidelity (FMR) ✦ | 43.58K | +29.0% | $94,571 | 0.0% | ▲ Add | 2 | SEC ↗ |
« Leur pondération » = la part de la position dans la valeur des actions 13F déclarées de ce gérant — la mesure de conviction. ✦ = gérant sélectionné.
Nouveaux acheteurs
| Aucun nouvel acheteur suivi ce trimestre. |
Sorti(e)
| Renaissance Technologies | $8.41M | était 0.0% |
| Marshall Wace | $191,264 | était 0.0% |
Contexte marché global: parmi TOUS les déposants 13F (données structurées SEC, Q1 2026): 282 détenteurs, 266.49M actions, $901.79M déclaré. Il s'agit d'une période différente et plus ancienne que les chiffres de l'univers suivi ci-dessus ; les deux ne sont jamais mélangés.
Ce que les détenteurs suivis de ce titre détiennent le plus souvent par ailleurs — nombre de détentions partagées, sans relation fondamentale sous-jacente.